Patent · US Active

Influenza hemagglutinin and neuraminidase variants

US8431137B2 · kind B2 · utility

2Cited by

29References

22Claims

0Family size

Assignee

MedImmune Limited · US

Inventors

Chin-Fen Yang · San Jose, US
George Kemble · Saratoga, US

Key dates

Filing date	Sep 12, 2011
Grant date	Apr 30, 2013
Priority date	—
Expiry date	Sep 12, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16164
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.